SPDR® S&P Biotech ETF

Shareclass
SPDR® S&P Biotech ETF (XBI)
Type
Exchange-traded fund
Gender equality score
Gender equality score

44
/ 100 points
Overall score
Average Equileap Gender Equality Score of fund holdings, weighted by market value
Peer rank
Group ranking

F
9.8
percentile

Universe: Groups

Group: Sector Equity

Ranking: 775 out of 858 funds


See more funds from this group
 All funds
 Groups
 Categories
Gender balance in leadership and workforce
Gender balance in leadership and workforce
24/40
See the score criteria
Equal compensation and work life balance
Equal compensation and work life balance
5/30
See the score criteria
Policies promoting gender equality
Policies promoting gender equality
14/20
See the score criteria
Commitment, transparency, and accountability
Commitment, transparency, and accountability
0/10
See the score criteria
Top scoring holdings
Top scoring holdings
The top 10 holdings in this portfolio with the best scores on the Equileap Gender Scorecard. In the case of ties, the holding with more assets invested is listed higher.
  • 1. Biogen Inc
    2.3% of assets
    $110.96M invested
  • 2. Neurocrine Biosciences Inc
    2.46% of assets
    $119M invested
  • 3. Amgen Inc
    2.33% of assets
    $112.48M invested
  • 4. BioMarin Pharmaceutical Inc
    2.34% of assets
    $113.06M invested
  • 5. AbbVie Inc
    2.36% of assets
    $113.96M invested
  • 6. Regeneron Pharmaceuticals Inc
    2.46% of assets
    $119.03M invested
  • 7. Gilead Sciences Inc
    2.47% of assets
    $119.25M invested
  • 8. Cytokinetics Inc
    1.42% of assets
    $68.48M invested
  • 9. Halozyme Therapeutics Inc
    2.35% of assets
    $113.57M invested
  • 10. Vertex Pharmaceuticals Inc
    2.39% of assets
    $115.67M invested
Bottom scoring holdings
Bottom scoring holdings
The bottom 10 holdings in this portfolio with the worst scores on the Equileap Gender Scorecard. In the case of ties, the holding with more assets invested is listed higher.
  • 1. GRAIL Inc
    0.53% of assets
    $25.8M invested
  • 2. TG Therapeutics Inc
    1.71% of assets
    $82.84M invested
  • 3. SpringWorks Therapeutics Inc Ordinary Shares
    1.36% of assets
    $65.52M invested
  • 4. Dyne Therapeutics Inc Ordinary Shares
    0.27% of assets
    $12.84M invested
  • 5. Nuvalent Inc Class A
    0.93% of assets
    $45.15M invested
  • 6. ADMA Biologics Inc
    1.23% of assets
    $59.22M invested
  • 7. Viking Therapeutics Inc
    1.06% of assets
    $51.04M invested
  • 8. CRISPR Therapeutics AG
    1.41% of assets
    $68.02M invested
  • 9. ACADIA Pharmaceuticals Inc
    0.69% of assets
    $33.17M invested
  • 10. Kymera Therapeutics Inc Ordinary Shares
    0.44% of assets
    $21.42M invested
Find sustainably-invested mutual funds and ETFs



Search for funds from your 401(k), retirement plan, or personal portfolio
Financial performance
Performance data provided byMorningstarFind more financial data on XBI at Morningstar.com
Gender Equality and Returns
Returns chart for SPDR® S&P Biotech ETF
Enlarge
The figure above charts annualized returns and Gender Equality Fund grades. The orange marker represents this fund. The purple marker (if present) represents an assigned benchmark. Blue dots represent funds in the same Morningstar category as this fund. Dark gray dots represent funds in the same grading group as this fund. Returns are for the most recent available for this fund of 1, 3, 5, or 10 year annualized returns. The higher a fund is marked on the Y axis, the better its returns for the specified time period. The higher a fund is marked on the X axis, the better its Gender Equality Funds group ranking. Read more on the How it Works page.
Benchmarking tool
Current fund
XBI
SPDR® S&P Biotech ETF
Family
State Street
Category
Health
vs.
Benchmark
ACWI
iShares MSCI ACWI ETF
Family
iShares from BlackRock
Category
Global Large-Stock Blend
Fund comparison settings
Investment timeline
Performance as of: 6/30/25
1 year
3 years
5 years
10 years
Benchmark
Suggested: MSCI ACWI
ACWI - iShares MSCI ACWI ETF
Fund comparison results
Compared to the benchmark, this fund has:
Lower 10-yr returns 
10% less  in annualized returns
Lower overall gender equality score 
11 / 100 points lower
Lower gender balance in leadership and workforce score 
2 / 40 points lower
Lower equal compensation and work life balance score 
5 / 30 points lower
Lower policies promoting gender equality score 
4 / 20 points lower
Lower commitment, transparency, and accountability score 
1 / 10 points lower
Current fund
XBI
SPDR® S&P Biotech ETF
Family
State Street
Category
Health
vs.
Benchmark
ACWI
iShares MSCI ACWI ETF
Family
iShares from BlackRock
Category
Global Large-Stock Blend
Fund comparison settings
Investment timeline
Performance as of: 6/30/25
1 year
3 years
5 years
10 years
Benchmark
Suggested: MSCI ACWI
ACWI - iShares MSCI ACWI ETF
Fund comparison results
Compared to the benchmark, this fund has:
Lower 10-yr returns 
10% less  in annualized returns
Lower overall gender equality score 
11 / 100 points lower
Lower gender balance in leadership and workforce score 
2 / 40 points lower
Lower equal compensation and work life balance score 
5 / 30 points lower
Lower policies promoting gender equality score 
4 / 20 points lower
Lower commitment, transparency, and accountability score 
1 / 10 points lower
Current fund
XBI
SPDR® S&P Biotech ETF
Family
State Street
Category
Health
vs.
Benchmark
ACWI
iShares MSCI ACWI ETF
Family
iShares from BlackRock
Category
Global Large-Stock Blend
Fund comparison settings
Investment timeline
Performance as of: 6/30/25
1 year
3 years
5 years
10 years
Benchmark
Suggested: MSCI ACWI
ACWI - iShares MSCI ACWI ETF
Fund comparison results
Compared to the benchmark, this fund has:
Lower 10-yr returns 
10% less  in annualized returns
Lower overall gender equality score 
11 / 100 points lower
Lower gender balance in leadership and workforce score 
2 / 40 points lower
Lower equal compensation and work life balance score 
5 / 30 points lower
Lower policies promoting gender equality score 
4 / 20 points lower
Lower commitment, transparency, and accountability score 
1 / 10 points lower
Month-end trailing returns  
Annualized returns
Gender-lens analysis
1-yr
3-yr
5-yr
10-yr
Overall gender equality score
This fund
XBI - SPDR® S&P Biotech ETF
-10.57%
3.8%
-5.77%
0%
44  / 100 points
Benchmark
ACWI - iShares MSCI ACWI ETF
16%
17%
14%
10%
55  / 100 points
Fund compared to benchmark
 
-26.99%
-13.57%
-19.48%
-10.15%
11  / 100 points lower
Find more financial data on XBI at Morningstar.com
What's next?
Learn how to make a change and move your money
Get started with our action toolkit
Ask your employer about gender-lens investing in your retirement plan
Find socially responsible funds that invest in gender equality
Learn more about As You Sow's Invest Your Values program
Visit Fossil Free Funds to measure the climate risk of this portfolio
More from Invest Your Values
See how mutual funds and ETFs are rated on issues ranging from fossil fuels, to deforestation, gender equality, guns, prisons, weapons, and tobacco

Disclaimer: As You Sow is not an investment adviser

As You Sow is not an investment adviser as that term is defined under federal and state (California) laws and regulations. As You Sow is a tax-exempt, nonprofit organization dedicated to educating and empowering shareholders to change corporations for the good through the collection, analysis and dissemination of relevant information to the public, free of charge. As You Sow does not provide financial planning, legal or tax advice. Nothing on this website shall constitute or be construed as an offering of financial instruments, or as investment advice or investment recommendations.
See our full disclaimer